The goal of this observational study aims to observe and evaluate the efficacy and safety of a liposomal doxorubicin containing regimen in the postoperative adjuvant treatment of breast cancer patients.
Female, aged 18-75 years;
Primary breast cancer diagnosed histopathologically;
Adjuvant chemotherapy regimens include liposomal doxorubicin;
ECoG PS score: 0-1 points;
Pregnant, lactating patients;
Breast cancer has been found to have distant metastasis;
Those with peripheral nervous system disorders caused by the disease or with a history of significant mental disorders and central nervous system disorders;
Those with severe infection or active peptic ulcer requiring treatment;
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead sponsor